These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 20961515)

  • 41. Hospital-Onset Staphylococcus aureus Bacteremia Is A Better Measure Than MRSA Bacteremia for Assessing Infection Prevention: Evaluation of 50 US Hospitals.
    Fakih MG; Battjes R; Sturm L; Jones L; Groves C; Bufalino A; Hendrich A
    Infect Control Hosp Epidemiol; 2018 Apr; 39(4):476-478. PubMed ID: 29429428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Economic burden of methicillin-resistant Staphylococcus aureus bacteremia in critical care patients in hospitals in Bogotá].
    Barrero LI; Castillo JS; Leal AL; Sánchez R; Cortés JA; Alvarez CA; González AL
    Biomedica; 2014; 34(3):345-53. PubMed ID: 25504122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methicillin-resistant Staphylococcus aureus: the superbug.
    Ippolito G; Leone S; Lauria FN; Nicastri E; Wenzel RP
    Int J Infect Dis; 2010 Oct; 14 Suppl 4():S7-11. PubMed ID: 20851011
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infection and the molecular characteristics of MRSA bacteraemia over a two-year period in a tertiary teaching hospital in Malaysia.
    Sit PS; Teh CS; Idris N; Sam IC; Syed Omar SF; Sulaiman H; Thong KL; Kamarulzaman A; Ponnampalavanar S
    BMC Infect Dis; 2017 Apr; 17(1):274. PubMed ID: 28407796
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimicrobial susceptibility patterns of community- and hospital-acquired methicillin-resistant Staphylococcus aureus from United States Hospitals: results from the AWARE Ceftaroline Surveillance Program (2012-2014).
    Sader HS; Mendes RE; Jones RN; Flamm RK
    Diagn Microbiol Infect Dis; 2016 Sep; 86(1):76-9. PubMed ID: 27394637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Community-acquired methicillin-resistant Staphylococcus aureus: Review].
    Del Giudice P; Tattevin P; Etienne J
    Presse Med; 2012 Jul; 41(7-8):713-20. PubMed ID: 22178559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiology and surveillance of methicillin-resistant staphylococcus aureus in Latin America.
    Mejía C; Zurita J; Guzmán-Blanco M
    Braz J Infect Dis; 2010 Dec; 14 Suppl 2():S79-86. PubMed ID: 21180928
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methicillin-resistant Staphylococcus aureus control in the 21st century: beyond the acute care hospital.
    Navarro MB; Huttner B; Harbarth S
    Curr Opin Infect Dis; 2008 Aug; 21(4):372-9. PubMed ID: 18594289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A small proportion of community-associated methicillin-resistant Staphylococcus aureus bacteraemia, compared to healthcare-associated cases, in two South African provinces.
    Perovic O; Singh-Moodley A; Govender NP; Kularatne R; Whitelaw A; Chibabhai V; Naicker P; Mbelle N; Lekalakala R; Quan V; Samuel C; Van Schalkwyk E;
    Eur J Clin Microbiol Infect Dis; 2017 Dec; 36(12):2519-2532. PubMed ID: 28849285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of incidence of bloodstream infection with methicillin-resistant Staphylococcus aureus between England and United States, 2006-2007.
    Lessa FC; Mu Y; Davies J; Murray M; Lillie M; Pearson A; Fridkin SK;
    Clin Infect Dis; 2010 Oct; 51(8):925-8. PubMed ID: 20815734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA).
    Mediavilla JR; Chen L; Mathema B; Kreiswirth BN
    Curr Opin Microbiol; 2012 Oct; 15(5):588-95. PubMed ID: 23044073
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Latin America.
    Guzmán-Blanco M; Mejía C; Isturiz R; Alvarez C; Bavestrello L; Gotuzzo E; Labarca J; Luna CM; Rodríguez-Noriega E; Salles MJ; Zurita J; Seas C
    Int J Antimicrob Agents; 2009 Oct; 34(4):304-8. PubMed ID: 19625169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007.
    Burton DC; Edwards JR; Horan TC; Jernigan JA; Fridkin SK
    JAMA; 2009 Feb; 301(7):727-36. PubMed ID: 19224749
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Australian Group on Antimicrobial Resistance Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2014.
    Coombs GW; Daley DA; Thin Lee Y; Pearson JC; Robinson JO; Nimmo GR; Collignon P; Howden BP; Bell JM; Turnidge JD;
    Commun Dis Intell Q Rep; 2016 Jun; 40(2):E244-54. PubMed ID: 27522136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methicillin-resistant Staphylococcus aureus in orthopaedic surgery.
    Patel A; Calfee RP; Plante M; Fischer SA; Arcand N; Born C
    J Bone Joint Surg Br; 2008 Nov; 90(11):1401-6. PubMed ID: 18978255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections.
    Moore CL; Hingwe A; Donabedian SM; Perri MB; Davis SL; Haque NZ; Reyes K; Vager D; Zervos MJ
    Int J Antimicrob Agents; 2009 Aug; 34(2):148-55. PubMed ID: 19394801
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differences between "classical" risk factors for infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and risk factors for nosocomial bloodstream infections caused by multiple clones of the staphylococcal cassette chromosome mec type IV MRSA strain.
    Vidal PM; Trindade PA; Garcia TO; Pacheco RL; Costa SF; Reinert C; Hiramatsu K; Mamizuka EM; Garcia CP; Levin AS
    Infect Control Hosp Epidemiol; 2009 Feb; 30(2):139-45. PubMed ID: 19146463
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of microbiological and clinical characteristics based on SCCmec typing in patients with community-onset meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia.
    Kuo SC; Chiang MC; Lee WS; Chen LY; Wu HS; Yu KW; Fung CP; Wang FD
    Int J Antimicrob Agents; 2012 Jan; 39(1):22-6. PubMed ID: 21982834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs?
    Abramson MA; Sexton DJ
    Infect Control Hosp Epidemiol; 1999 Jun; 20(6):408-11. PubMed ID: 10395142
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Horizontal infection control strategy decreases methicillin-resistant Staphylococcus aureus infection and eliminates bacteremia in a surgical ICU without active surveillance.
    Traa MX; Barboza L; Doron S; Snydman DR; Noubary F; Nasraway SA
    Crit Care Med; 2014 Oct; 42(10):2151-7. PubMed ID: 24979485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.